Cannabis rescheduling plans spark concerns among GOP senators
Seeking Alpha News (Wed, 27-Mar 12:42 PM ET)
GOP committee opposes cannabis banking bill; calls marijuana 'gateway drug'
Seeking Alpha News (Tue, 26-Mar 11:34 AM ET)
Americans overwhelmingly support cannabis banking reform - poll
Seeking Alpha News (Mon, 25-Mar 3:06 PM ET)
Biggest stock movers today: BA, UAL, DWAC, ACB, and more
Seeking Alpha News (Mon, 25-Mar 10:11 AM ET)
Biggest stock movers today: BA, DWAC, ACB, and more
Seeking Alpha News (Mon, 25-Mar 8:30 AM ET)
Biggest stock movers today: DWAC, ACB, and more
Seeking Alpha News (Mon, 25-Mar 5:23 AM ET)
Germany cannabis legalization on schedule as bill clears final hurdle
Seeking Alpha News (Sat, 23-Mar 2:11 PM ET)
PRNewswire (Wed, 20-Mar 7:15 AM ET)
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
PRNewswire (Mon, 4-Mar 9:42 AM ET)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of March 28, 2024, ACB stock price declined to $4.59 with 6,960,874 million shares trading.
ACB has a beta of 1.57, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.03 to the broad based SPY ETF.
ACB has a market cap of $250.34 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $47 million in Revenue and -$.40 earnings per share. This beat revenue expectation by $481,000 and missed earnings estimates by -$.30.
In the last 3 years, ACB stock traded as high as $106.40 and as low as $2.84.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, GWX.
ACB has underperformed the market in the last year with a return of -35.1%, while the SPY ETF gained +33.7%. In the last 3 month period, ACB fell short of the market, returning -7.3%, while SPY returned +10.2%. However, in the most recent 2 weeks ACB has outperformed the stock market by returning +54.5%, while SPY returned +1.7%.
ACB support price is $4.41 and resistance is $5.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB stock will trade within this expected range on the day.